These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Unlocking the opportunity of tight glycaemic control. Far from goal. Del Prato S Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133 [TBL] [Abstract][Full Text] [Related]
4. Insulin and oral hypoglycaemic agents. II. Clinical and therapeutic aspects. Breidahl HD; Ennis GC; Martin FI; Stawell JR; Taft P Drugs; 1972; 3(3):204-26. PubMed ID: 4561637 [No Abstract] [Full Text] [Related]
5. [Trust is good, control is better. Glucose tests, insulin syringes, needles]. Fink E Pharm Unserer Zeit; 2001 Jan; 30(1):34-9. PubMed ID: 11233181 [No Abstract] [Full Text] [Related]
6. Can we reduce hypoglycaemia with insulin detemir? Mathieu C Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S35-40. PubMed ID: 15306836 [TBL] [Abstract][Full Text] [Related]
7. Strategies for managing the diabetic patient. Robertshaw HJ; McAnulty GR; Hall GH Best Pract Res Clin Anaesthesiol; 2004 Dec; 18(4):631-43. PubMed ID: 15460549 [TBL] [Abstract][Full Text] [Related]
9. Effect of trimethoprim-sulfamethoxazole on blood insulin and glucose concentrations of diabetics. Mihic M; Mautner LS; Feness JZ; Grant K Can Med Assoc J; 1975 Jun; 112(13 Spec No):80-2. PubMed ID: 1137831 [TBL] [Abstract][Full Text] [Related]
10. [Therapeutic education and continuous glucose monitoring in insulin-treated diabetic patients]. Thielen V; Radermecker RP; Renard E; Bringer J; Scheen AJ Rev Med Suisse; 2010 Sep; 6(260):1596-600. PubMed ID: 20853714 [TBL] [Abstract][Full Text] [Related]
11. Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus. Reynolds NA; Wagstaff AJ Drugs; 2004; 64(17):1957-74. PubMed ID: 15329046 [TBL] [Abstract][Full Text] [Related]
12. Tight glycaemic control using soluble insulin benefits critically ill patients during hospitalisation. Cardiovasc J S Afr; 2006; 17(4):218. PubMed ID: 17001433 [No Abstract] [Full Text] [Related]
13. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide]. Vogel G; Krummel E Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514 [No Abstract] [Full Text] [Related]
14. Evolving strategies for insulin delivery and therapy. Cefalu WT Drugs; 2004; 64(11):1149-61. PubMed ID: 15161324 [TBL] [Abstract][Full Text] [Related]
15. [Changes of serum insulin during fasting and glucose loading before and after treatment of diabetes]. Kosaka K; Hagura R; Ogawara H Dtsch Med J; 1970 Apr; 21(8):554-64. PubMed ID: 5510200 [No Abstract] [Full Text] [Related]
16. Current practice in the perioperative management of patients with diabetes mellitus: a narrative review. Crowley K; Scanaill PÓ; Hermanides J; Buggy DJ Br J Anaesth; 2023 Aug; 131(2):242-252. PubMed ID: 37061429 [TBL] [Abstract][Full Text] [Related]
17. [Initial treatment and prognosis of diabetes mellitus]. Lohmann D; Kunze U; Schüritz P; Steltz G Dtsch Gesundheitsw; 1969 Feb; 24(7):296-301. PubMed ID: 5386441 [No Abstract] [Full Text] [Related]
18. [Current issues in the therapy of diabetes mellitus]. Halmos T Orv Hetil; 2004 Nov; 145(47):2363-70. PubMed ID: 15641668 [TBL] [Abstract][Full Text] [Related]